219.66

0.68% 1.535

Iqvia Holdings Inc (IQV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$218.13

Aprire:

$220

Volume 24 ore:

421.52K

Relative Volume:

0.30

Capitalizzazione di mercato:

$37.35B

Reddito:

$15.70B

Utile/perdita netta:

$1.24B

Rapporto P/E:

31.82

EPS:

6.9036

Flusso di cassa netto:

$2.01B

1 W Prestazione:

+0.80%

1M Prestazione:

+21.52%

6M Prestazione:

+43.11%

1 anno Prestazione:

+1.51%

Intervallo 1D:

$215.75

$222.59

Intervallo di 1 settimana:

$209.46

$225.00

Portata 52W:

$134.65

$225.91

Iqvia Holdings Inc Stock (IQV) Company Profile

Nome

Iqvia Holdings Inc

Settore

Healthcare (1141)

Industria

Diagnostics & Research (53)

Telefono

919-998-2000

Indirizzo

2400 ELLIS ROAD, DURHAM, NC

Dipendente

90,000

Cinguettio

@IQVIA_global

Prossima data di guadagno

2025-07-22

Ultimi documenti SEC

IQV's Discussions on Twitter

Confronta IQV con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IQV Iqvia Holdings Inc	219.71	37.15B	15.70B	1.24B	2.01B	6.9036
TMO Thermo Fisher Scientific Inc	564.29	210.57B	43.74B	6.59B	6.11B	17.30
DHR Danaher Corp	216.73	153.21B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	630.40	50.75B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	144.92	41.35B	6.79B	1.22B	1.09B	4.2644

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-09	Aggiornamento	HSBC Securities	Hold → Buy
2025-09-09	Aggiornamento	Jefferies	Hold → Buy
2025-04-25	Downgrade	HSBC Securities	Buy → Hold
2025-04-10	Downgrade	Barclays	Overweight → Equal Weight
2025-02-03	Downgrade	BTIG Research	Buy → Neutral
2024-12-20	Iniziato	Stephens	Overweight
2024-10-14	Iniziato	Redburn Atlantic	Buy
2024-09-04	Iniziato	RBC Capital Mkts	Outperform
2024-07-24	Downgrade	Jefferies	Buy → Hold
2024-06-06	Iniziato	Goldman	Buy
2024-02-26	Iniziato	Leerink Partners	Outperform
2024-02-15	Downgrade	Guggenheim	Buy → Neutral
2024-02-13	Iniziato	BTIG Research	Buy
2023-11-02	Downgrade	Robert W. Baird	Outperform → Neutral
2023-09-06	Iniziato	HSBC Securities	Buy
2023-03-17	Iniziato	Truist	Buy
2022-12-06	Iniziato	Cowen	Outperform
2022-11-17	Downgrade	Citigroup	Buy → Neutral
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-15	Iniziato	SVB Leerink	Outperform
2022-05-24	Iniziato	Guggenheim	Buy
2022-04-29	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-04-16	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-03-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Iniziato	Barclays	Overweight
2020-07-07	Iniziato	Stephens	Equal-Weight
2020-03-02	Iniziato	Deutsche Bank	Buy
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Buy
2019-12-13	Aggiornamento	CFRA	Sell → Hold
2019-11-14	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2019-06-21	Aggiornamento	Mizuho	Neutral → Buy
2019-05-28	Iniziato	SVB Leerink	Outperform
2019-01-18	Aggiornamento	Jefferies	Hold → Buy
2018-10-09	Iniziato	UBS	Buy
2018-10-02	Reiterato	Robert W. Baird	Outperform
2018-07-25	Aggiornamento	BofA/Merrill	Neutral → Buy
2018-07-25	Reiterato	Stifel	Buy
2018-07-03	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-04-13	Aggiornamento	Goldman	Neutral → Buy
2018-03-07	Aggiornamento	SunTrust	Hold → Buy
2018-01-19	Iniziato	Evercore ISI	Outperform

Mostra tutto

Iqvia Holdings Inc Borsa (IQV) Ultime notizie

09:25 AM

Truist Raises Price Target on IQVIA Holdings to $265 From $235, Keeps Buy Rating - MarketScreener

09:25 AM

08:16 AM

IQVIA Holdings Inc. (NYSE:IQV) Q3 2025 Earnings Call Transcript - Insider Monkey

08:16 AM

08:10 AM

IQV: Baird Upgrades and Raises Price Target to $258 | IQV Stock News - GuruFocus

08:10 AM

07:00 AM

Is IQVIA Holdings Inc. stock at risk of policy regulationJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com

07:00 AM

06:14 AM

IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates - sharewise.com

06:14 AM

05:38 AM

Baird Upgrades IQVIA Holdings to Outperform From Neutral, Adjusts Price Target to $258 From $224 - MarketScreener

05:38 AM

03:41 AM

Is IQVIA Holdings Inc. building a consolidation baseWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com

03:41 AM

12:18 PM

IQVIA sees record $772M free cash flow and reaffirms 2025 guidance while advancing AI and commercial outsourcing - MSN

Oct 28, 2025

Insider Trends: Will IQVIA Holdings Inc. stock benefit from sector leadershipMarket Growth Review & Fast Entry High Yield Tips - Fundação Cultural do Pará

Oct 28, 2025

IQVIA narrows annual profit forecast amid continued research contract cancellations - Reuters

Oct 28, 2025

IQV Revises Q4 Revenue and EBITDA Forecasts - GuruFocus

Oct 28, 2025

Earnings call transcript: IQVIA Q3 2025 beats expectations, stock dips By Investing.com - Investing.com Nigeria

Oct 28, 2025

Earnings call transcript: IQVIA Q3 2025 beats expectations, stock dips - Investing.com

Oct 28, 2025

IQVIA Tops Forecasts As Demand For Health Data Grows - Finimize

Oct 28, 2025

Why IQVIA Holdings Inc. stock stays undervaluedTrade Volume Summary & Technical Pattern Alert System - Fundação Cultural do Pará

Oct 28, 2025

IQV Updates Financial Outlook for Fiscal Year 2025 - GuruFocus

Oct 28, 2025

IQVIA Reports Third-Quarter 2025 Results - BioSpace

Oct 28, 2025

(IQV) IQVIA Expects Full Year 2025 Adjusted EPS Range $11.85$11.95, vs. FactSet Est of $11.87 - MarketScreener

Oct 28, 2025

Earnings Flash (IQV) IQVIA Holdings Inc. Reports Q3 Revenue $4.10B, vs. FactSet Est of $4.08B - MarketScreener

Oct 28, 2025

Earnings Flash (IQV) IQVIA Holdings Inc. Posts Q3 Adjusted EPS $3.00 per Share, vs. FactSet Est of $2.98 - MarketScreener

Oct 28, 2025